Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling

Neoplasia (United States)

Volumn 15, Issue 7, 2013, Pages 712-719

  Ghanbari Azarnier, Ronak ^a,b   Sato, Shingo ^a   Wei, Qingxia ^a   Al Jazrawe, Mushriq ^a,b   Alman, Benjamin A ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GREEN FLUORESCENT PROTEIN; PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR GLI1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOLUMINESCENCE; COLONY FORMING UNIT; CONTROLLED STUDY; DENSITOMETRY; DESMOID TUMOR; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84879627647     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.13452     Document Type: Article

References (52)

1. Alman BA, Pajerski ME, Diaz-Cano S, Corboy K, and Wolfe HJ (1997). Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 6, 98-101.
2. Lewis JJ, Boland PJ, Leung DH, Woodruff JM, and Brennan MF (1999). The enigma of desmoid tumors. Ann Surg 229, 866-872; discussion 872-863.
3. Shields CJ, Winter DC, Kirwan WO, and Redmond HP (2001). Desmoid tumours. Eur J Surg Oncol 27, 701-706.
4. Lips DJ, Barker N, Clevers H, and Hennipman A (2009). The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors). Eur J Surg Oncol 35, 3-10.
5. Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV, Kerr MC, and Hamilton SR (1994). Desmoid tumours in familial adenomatous polyposis. Gut 35, 377-381.
6. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman J. J, et al. (1999). Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18, 6615-6620.
7. Alman BA, Li C, Pajerski ME, Diaz-Cano S, and Wolfe HJ (1997). Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151, 329-334.
8. Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R, Van Cutsem E, Cassiman JJ, and Alman BA (2001). Tcf-3 expression and β-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). Br J Cancer 85, 98-101.
9. Cheon SS, Cheah AY, Turley S, Nadesan P, Poon R, Clevers H, and Alman BA (2002). β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 99, 6973-6978.
10. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M, Khan PM, et al. (1994). A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 91, 8969-8973.
11. Smits R, van der Houven van Oordt W, Luz A, Zurcher C, Jagmohan-Changur S, Breukel C, Khan PM, and Fodde R (1998). Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology 114, 275-283.
12. Aberle H, Bauer A, Stappert J, Kispert A, and Kemler R (1997). β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16, 3797-3804.
13. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, and Polakis P (1996). Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 272, 1023-1026.
14. Jiang J and Hui CC (2008). Hedgehog signaling in development and cancer. Dev Cell 15, 801-812.
15. Varjosalo M and Taipale J (2008). Hedgehog: functions and mechanisms. Genes Dev 22, 2454-2472.
16. Mo R, Freer AM, Zinyk DL, Crackower MA, Michaud J, Heng HH, Chik KW, Shi XM, Tsui LC, Cheng SH, et al. (1997). Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124, 113-123.
17. Ding Q, Motoyama J, Gasca S, Mo R, Sasaki H, Rossant J, and Hui CC (1998). Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. Development 125, 2533-2543.
18. Bai CB, Auerbach W, Lee JS, Stephen D, and Joyner AL (2002). Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. Development 129, 4753-4761.
19. Wu C, Amini-Nik S, Nadesan P, Stanford WL, and Alman BA (2010). Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells. Cancer Res 70, 7690-7698.
20. Carothers AM, Rizvi H, Hasson RM, Heit YI, Davids JS, Bertagnolli MM, and Cho NL (2012). Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors. Cancer Res 72, 346-355.
21. Plaisant M, Giorgetti-Peraldi S, Gabrielson M, Loubat A, Dani C, and Peraldi P (2011). Inhibition of hedgehog signaling decreases proliferation and clonogenicity of human mesenchymal stem cells. PLoS One 6, e16798.
22. Plaisant M, Fontaine C, Cousin W, Rochet N, Dani C, and Peraldi P (2009). Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells. Stem Cells 27, 703-713.
23. Fontaine C, Cousin W, Plaisant M, Dani C, and Peraldi P (2008). Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells. Stem Cells 26, 1037-1046.
24. Jiang J and Struhl G (1998). Regulation of the Hedgehog and Wingless signaling pathways by the F-box/WD40-repeat protein Slimb. Nature 391, 493-496.
25. Mullor JL, Dahmane N, Sun T, and Ruiz i Altaba A (2001). Wnt signals are targets and mediators of Gli function. Curr Biol 11, 769-773.
26. van den Brink GR, Bleuming SA, Hardwick JC, Schepman BL, Offerhaus GJ, Keller JJ, Nielsen C, Gaffield W, van Deventer SJ, Roberts DJ, et al. (2004). Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet 36, 277-282.
27. Pasca di Magliano M, Biankin AV, Heiser PW, Cano DA, Gutierrez PJ, Deramaudt T, Segara D, Dawson AC, Kench JG, Henshall SM, et al. (2007). Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS One 2, e1155.
28. Yang SH, Andl T, Grachtchouk V, Wang A, Liu J, Syu LJ, Ferris J, Wang TS, Glick AB, Millar SE, et al. (2008). Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling. Nat Genet 40, 1130-1135.
29. Dakubo GD, Mazerolle CJ, and Wallace VA (2006). Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice. J Neurooncol 79, 221-227.
30. Akiyoshi T, Nakamura M, Koga K, Nakashima H, Yao T, Tsuneyoshi M, Tanaka M, and Katano M (2006). Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Gut 55, 991-999.
31. Arimura S, Matsunaga A, Kitamura T, Aoki K, Aoki M, and Taketo MM (2009). Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. Gastroenterology 137, 629-638.
32. Maeda O, Kondo M, Fujita T, Usami N, Fukui T, Shimokata K, Ando T, Goto H, and Sekido Y (2006). Enhancement of GLI1-transcriptional activity by β-catenin in human cancer cells. Oncol Rep 16, 91-96.
33. LoRusso PM, Rudin CM, Reddy JC, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Chang I, Darbonne WC, et al. (2011). Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res 17, 2502-2511.
34. Wu C, Wei Q, Utomo V, Nadesan P, Whetstone H, Kandel R, Wunder JS, and Alman BA (2007). Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res 67, 8216-8222.
35. Hong H, Nadesan P, Poon R, and Alman BA (2011). Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour). Br J Cancer 104, 1452-1458.
36. Pavletich NP and Pabo CO (1993). Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science 261, 1701-1707.
37. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, and Taketo MM (1999). Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene. EMBO J 18, 5931-5942.
38. Cooper MK, Porter JA, Young KE, and Beachy PA (1998). Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280, 1603-1607.
39. Hopyan S, Nadesan P, Yu C, Wunder J, and Alman BA (2005). Dysregulation of hedgehog signalling predisposes to synovial chondromatosis. J Pathol 206, 143-150.
40. Chevy F, Illien F, Wolf C, and Roux C (2002). Limb malformations of rat fetuses exposed to a distal inhibitor of cholesterol biosynthesis. J Lipid Res 43, 1192-1200.
41. Amundson DM and Zhou M (1999). Fluorometric method for the enzymatic determination of cholesterol. J Biochem Biophys Methods 38, 43-52.
42. Hui CC and Angers S (2011). Gli proteins in development and disease. Annu Rev Cell Dev Biol 27, 513-537.
43. Poon R, Smits R, Li C, Jagmohan-Changur S, Kong M, Cheon S, Yu C, Fodde R, and Alman BA (2001). Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 20, 451-460.
44. Miller SC, Huang R, Sakamuru S, Shukla SJ, Attene-Ramos MS, Shinn P, Van Leer D, Leister W, Austin CP, and Xia M (2010). Identification of known drugs that act as inhibitors of NF-κB signaling and their mechanism of action. Biochem Pharmacol 79, 1272-1280.
45. -ΔΔCT method. Methods 25, 402-408.
46. Wood ER and Earnshaw WC (1990). Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II. J Cell Biol 111, 2839-2850.
47. Meng X, Poon R, Zhang X, Cheah A, Ding Q, Hui CC, and Alman B (2001). Suppressor of fused negatively regulates β-catenin signaling. J Biol Chem 276, 40113-40119.
48. Friedenstein AJ, Chailakhjan RK, and Lalykina KS (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3, 393-403.
49. Phinney DG, Kopen G, Isaacson RL, and Prockop DJ (1999). Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 72, 570-585.
50. Teglund S and Toftgard R (2010). Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 1805, 181-208.
51. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, et al. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856.
52. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, and Beachy PA (2004). Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707-712.